Literature DB >> 15679054

A fluorescent orthotopic mouse model for reliable measurement and genetic modulation of human neuroblastoma metastasis.

K Cecilia Henriksson1, Malin A E Almgren, Ralph Thurlow, Nissi M Varki, Christina L Chang.   

Abstract

Neuroblastoma is the most common extra-cranial solid tumor of infancy and childhood, and majority of patients die from the metastatic disease. Orthotopic xenograft mouse models are valuable tools for improving our understanding and control of neuroblastoma metastasis, because they readily represent genetic diversity and allow spontaneous metastasis. Intra-adrenal injection is commonly used for establishing the orthotopic animal models since human neuroblastoma frequently originates in the adrenal gland. However, it is unclear whether the metastatic potential of neuroblastoma can be reliably determined in adrenally-injected mice because their gland size is so small. In this study, we developed and characterized a fluorescent orthotopic xenograft animal model of NB69-derived human neuroblastoma. By comparing animals receiving adrenal injection and adrenal overlay, with the latter mimicking injection spillover, we found that the metastatic potential of neuroblastoma can be reliably determined in animal lungs. Furthermore, the lung metastasis can be genetically modulated in these animals. The results also show that the expression of Renilla green fluorescent protein (GFP) was exceptionally stable in NB69 cells, allowing rapid and sensitive detection of lung metastases at the macroscopic level. Additional features of our model include 100% tumor take, a 1-week tumor latency, resemblance to tumor behaviors in neuroblastoma patients, and the ability to monitor the expression of a gene of interest with GFP. This animal model of human neuroblastoma will be useful for studying genes involved in the metastatic process and for evaluating anti-metastasis agents in pre-clinical trials.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15679054     DOI: 10.1007/s10585-004-4091-5

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  27 in total

1.  Development, characterization and therapy of a disseminated model of childhood neuroblastoma in SCID mice.

Authors:  J Thompson; S M Guichard; P J Cheshire; L B Richmond; C A Poquette; S T Ragsdale; B Webber; R Lorsbach; M K Danks; P J Houghton
Journal:  Cancer Chemother Pharmacol       Date:  2001-03       Impact factor: 3.333

Review 2.  Earliest steps in primary tumor formation and micrometastasis resolved with histochemical markers of gene-tagged tumor cells.

Authors:  L A Culp; W Lin; N R Kleinman; K L O'Connor; R Lechner
Journal:  J Histochem Cytochem       Date:  1998-05       Impact factor: 2.479

Review 3.  Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.

Authors:  Eric C Kauffman; Victoria L Robinson; Walter M Stadler; Mitchell H Sokoloff; Carrie W Rinker-Schaeffer
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

4.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.

Authors:  G M Brodeur; R C Seeger; M Schwab; H E Varmus; J M Bishop
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

Review 5.  Potential of the scid mouse as a host for human tumors.

Authors:  B M Mueller; R A Reisfeld
Journal:  Cancer Metastasis Rev       Date:  1991-10       Impact factor: 9.264

6.  Nucleoside diphosphate kinase A/nm23-H1 promotes metastasis of NB69-derived human neuroblastoma.

Authors:  Malin A E Almgren; K Cecilia E Henriksson; Jennifer Fujimoto; Christina L Chang
Journal:  Mol Cancer Res       Date:  2004-07       Impact factor: 5.852

7.  Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas.

Authors:  A Leone; R C Seeger; C M Hong; Y Y Hu; M J Arboleda; G M Brodeur; D Stram; D J Slamon; P S Steeg
Journal:  Oncogene       Date:  1993-04       Impact factor: 9.867

Review 8.  Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models.

Authors:  Robert Hoffman
Journal:  Lancet Oncol       Date:  2002-09       Impact factor: 41.316

9.  Two new human neuroblastoma cell lines exhibiting tumorigenesis and metastasis in the nude mouse model.

Authors:  C L Fowler; C C Zimmer; D Ruktanouchai; S G Zimmer
Journal:  Anticancer Res       Date:  1998 May-Jun       Impact factor: 2.480

10.  An increased NM23H1 copy number may be a poor prognostic factor independent of LOH on 1p in neuroblastomas.

Authors:  O Takeda; M Handa; T Uehara; N Maseki; A Sakashita; M Sakurai; N Kanda; Y Arai; Y Kaneko
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

View more
  8 in total

1.  Optimizing orthotopic cell transplantation in the mouse adrenal gland.

Authors:  Cibele C Cardoso; Stefan R Bornstein; Peter J Hornsby
Journal:  Cell Transplant       Date:  2010-06-03       Impact factor: 4.064

2.  Noninvasive optical tracking of red fluorescent protein-expressing cancer cells in a model of metastatic breast cancer.

Authors:  Paul T Winnard; Jessica B Kluth; Venu Raman
Journal:  Neoplasia       Date:  2006-10       Impact factor: 5.715

Review 3.  New methods for investigating experimental human adrenal tumorigenesis.

Authors:  Cibele C Cardoso; Stefan R Bornstein; Peter J Hornsby
Journal:  Mol Cell Endocrinol       Date:  2008-11-13       Impact factor: 4.102

4.  Generation and characterization of novel local and metastatic human neuroblastoma variants.

Authors:  Ido Nevo; Orit Sagi-Assif; Liat Edry Botzer; Dana Amar; Shelly Maman; Naam Kariv; Leonor E Leider-Trejo; Larissa Savelyeva; Manfred Schwab; Ilana Yron; Isaac P Witz
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

Review 5.  Molecular imaging of metastatic potential.

Authors:  Paul T Winnard; Arvind P Pathak; Surajit Dhara; Steven Y Cho; Venu Raman; Martin G Pomper
Journal:  J Nucl Med       Date:  2008-06       Impact factor: 10.057

6.  NDPKA is not just a metastasis suppressor - be aware of its metastasis-promoting role in neuroblastoma.

Authors:  Choon-Yee Tan; Christina L Chang
Journal:  Lab Invest       Date:  2017-10-09       Impact factor: 5.662

7.  Surgery combined with controlled-release doxorubicin silk films as a treatment strategy in an orthotopic neuroblastoma mouse model.

Authors:  B Chiu; J Coburn; M Pilichowska; C Holcroft; F P Seib; A Charest; D L Kaplan
Journal:  Br J Cancer       Date:  2014-06-12       Impact factor: 7.640

8.  Treatment of Neuroblastoma with an Engineered "Obligate" Anaerobic Salmonella typhimurium Strain YB1.

Authors:  Bo-Tao Ning; Bin Yu; Shing Chan; Jian-Liang Chan; Jian-Dong Huang; Godfrey Chi-Fung Chan
Journal:  J Cancer       Date:  2017-06-03       Impact factor: 4.207

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.